CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
2-0 dioxanone, glycolide and trimethylene carbonate +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04658784
NCT04658784N/ACompleted
CompareCT.gov

Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy: A Randomized Controlled Trial

Wake Forest University Health Sciences·interventional·Posted Dec 8, 2020·Updated May 6, 2023

In Brief

A clinical study evaluating 2-0 dioxanone, glycolide and trimethylene carbonate and 2-0 polydioxanone for Rectocele. Completed, enrolled 72 participants across 1 site.

Detailed Summary

The aim of this randomized clinical trial is to compare barbed suture versus non-barbed suture at the time of posterior repair on postoperative pain scores as measured by a visual analog scale (VAS) at 6 weeks. Study participants are randomized to use of barbed suture (2-0 V-Loc 90TM, Medtronic) or non-barbed suture (2-0 Polydioxanone, PDS® EthiconTM) in a standardized technique for posterior colporrhaphy at the time of posterior repair.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRectocele
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 8, 2020
Enrollment StartAug 14, 2020
Primary CompletionNov 5, 2021
Study CompletionDec 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.6 years ago

Interventions

2-0 dioxanone, glycolide and trimethylene carbonatedevice

delayed absorbable, monofilament barbed suture

2-0 polydioxanonedevice

delayed absorbable, monofilament non-barbed suture